CannaPharmaRx, Inc. (CPMD) stock
CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.54MP/E –Yield –
CannaPharmaRx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
CannaPharmaRx's operating cash flow for the twelve months ending Sep 30, 2026 was $523.77K. For fiscal 2025 it was -$789.10K. The highest annual figure on record is $0 in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$789.10K | – |
| FY2024 | Dec 31, 2024 | -$1.70M | – |
| FY2023 | Dec 31, 2023 | -$2.27M | – |
| FY2022 | Dec 31, 2022 | -$1.45M | – |
| FY2021 | Dec 31, 2021 | -$2.41M | – |
| FY2020 | Dec 31, 2020 | -$563.57K | – |
| FY2019 | Dec 31, 2019 | -$3.79M | – |
| FY2018 | Dec 31, 2018 | -$941.14K | – |
| FY2017 | Dec 31, 2017 | $0 | – |
| FY2016 | Dec 31, 2016 | -$22.38K | – |
| FY2015 | Dec 31, 2015 | -$2.55M | – |
| FY2014 | Dec 31, 2014 | -$1.54M | – |
| FY2013 | Dec 31, 2013 | -$11.02K | – |
| FY2012 | Dec 31, 2012 | -$10.91K | – |
| FY2011 | Dec 31, 2011 | -$12.10K | – |
| FY2010 | Dec 31, 2010 | $0 | – |
| FY2009 | Dec 31, 2009 | -$69.12K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$166.65K | – |
| Q2 FY2026 | Jun 30, 2026 | -$127.37K | – |
| Q1 FY2026 | Mar 31, 2026 | -$243.66K | – |
| Q4 FY2025 | Dec 31, 2025 | $1.06M | – |
| Q3 FY2025 | Sep 30, 2025 | -$802.70K | – |
| Q2 FY2025 | Jun 30, 2025 | -$446.46K | – |
| Q1 FY2025 | Mar 31, 2025 | -$601.38K | – |
| Q4 FY2024 | Dec 31, 2024 | -$179.89K | – |
| Q3 FY2024 | Sep 30, 2024 | -$540.90K | -536.6% |
| Q2 FY2024 | Jun 30, 2024 | -$427.62K | – |
| Q1 FY2024 | Mar 31, 2024 | -$548.83K | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.30M | – |
| Q3 FY2023 | Sep 30, 2023 | $123.88K | -62.3% |
| Q2 FY2023 | Jun 30, 2023 | -$482.17K | – |
| Q1 FY2023 | Mar 31, 2023 | -$611.74K | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.09M | – |
| Q3 FY2022 | Sep 30, 2022 | $328.33K | – |
| Q2 FY2022 | Jun 30, 2022 | -$310.04K | – |
| Q1 FY2022 | Mar 31, 2022 | -$375.18K | – |
| Q4 FY2021 | Dec 31, 2021 | -$327.29K | -221.8% |
| Q3 FY2021 | Sep 30, 2021 | -$1.03M | – |
| Q2 FY2021 | Jun 30, 2021 | -$256.45K | – |
| Q1 FY2021 | Mar 31, 2021 | -$799.25K | – |
| Q4 FY2020 | Dec 31, 2020 | $268.75K | – |
| Q3 FY2020 | Sep 30, 2020 | -$158.97K | – |
| Q2 FY2020 | Jun 30, 2020 | -$307.68K | – |
| Q1 FY2020 | Mar 31, 2020 | -$365.68K | – |
| Q4 FY2019 | Dec 31, 2019 | -$973.38K | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.34M | – |
| Q2 FY2019 | Jun 30, 2019 | -$309.86K | – |
| Q1 FY2019 | Mar 31, 2019 | -$176.52K | – |
| Q4 FY2018 | Dec 31, 2018 | -$734.89K | – |
| Q3 FY2018 | Sep 30, 2018 | -$168.46K | – |
| Q2 FY2018 | Jun 30, 2018 | -$37.78K | – |
| Q1 FY2018 | Mar 31, 2018 | $0 | – |
| Q4 FY2017 | Dec 31, 2017 | $0 | – |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q2 FY2017 | Jun 30, 2017 | $0 | – |
| Q1 FY2017 | Mar 31, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | -$1 | – |
See a number that looks wrong?